ACR Open Rheumatology, published by WILEY, is a premier open-access journal dedicated to advancing the field of rheumatology. Since its inception in 2019, this journal has rapidly gained recognition, achieving a Q1 category ranking in the 2023 Scopus Quartiles, positioning it among the top 30% within its discipline. With a current Scopus rank of 22 out of 73 in Medicine - Rheumatology and an impressive 70th percentile, ACR Open Rheumatology serves as a vital platform for researchers and clinicians to disseminate knowledge on the latest developments in rheumatic diseases and treatments. The journal promotes unrestricted access to cutting-edge research, thus fostering collaboration and innovation in the rheumatological community. Situated in the United States, it caters to a global audience, encouraging submissions from researchers worldwide and addressing critical health issues that affect millions. We invite professionals, students, and researchers alike to engage with the transformative findings published in our journal.

JOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

ANNALS OF THE RHEUMATIC DISEASES, published by BMJ Publishing Group, stands as a leading academic journal in the realm of rheumatology and related fields, including biochemistry, immunology, and genetics. With an esteemed impact factor and a consistent ranking in the upper echelons of its category (Q1) as per the latest evaluations, this journal represents the forefront of research and innovation, fostering scientific advancement from 1945 to the present. As the top journal in the Medicine - Rheumatology category and achieving remarkable percentiles in various interdisciplinary categories, it serves as a critical platform for researchers, clinicians, and students dedicated to understanding and addressing rheumatic diseases. Although it does not currently offer open access, its rigorous peer-review process ensures the dissemination of high-quality research findings that are paramount in enhancing clinical practices and advancing scientific discourse. Readers can expect to be challenged and inspired by the breadth of studies and reviews that address the complexities of rheumatology and its intersecting scientific domains.

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.